Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer.
about
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer ConsortiumA genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinomaPeripheral blood biomarkers in idiopathic pulmonary fibrosisMatrix metalloproteinase 1: role in sarcoma biologyNovel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer RiskMETA-GSA: Combining Findings from Gene-Set Analyses across Several Genome-Wide Association StudiesPrevious lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer ConsortiumInternational Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variantsHeritability of radiation response in lung cancer familiesAsthma and lung cancer risk: a systematic investigation by the International Lung Cancer ConsortiumInfluence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controlsDistinct biological events generated by ECM proteolysis by two homologous collagenasesMetabolic profiling reveals distinct variations linked to nicotine consumption in humans--first results from the KORA study.A network-based kernel machine test for the identification of risk pathways in genome-wide association studiesSimulating tumor microenvironment: changes in protein expression in an in vitro co-culture system.Acetylcholine receptor pathway in lung cancer: New twists to an old story.Comparison of pathway analysis approaches using lung cancer GWAS data setsPromoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma.Lung cancer transcriptomes refined with laser capture microdissection.Cdc25A regulates matrix metalloprotease 1 through Foxo1 and mediates metastasis of breast cancer cells.CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases.Informed genome-wide association analysis with family history as a secondary phenotype identifies novel loci of lung cancer.miR-526b targets 3' UTR of MMP1 mRNA.Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia.Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions.RNA-seq analysis of lung adenocarcinomas reveals different gene expression profiles between smoking and nonsmoking patients.Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls.Expression of inflammation-mediated cluster of genes as a new marker of canine mammary malignancy.Association of matrix metalloproteinase-1 polymorphisms with risk of COPD and lung cancer and survival in lung cancer.Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses.Investigation of MMP-1 genetic polymorphisms and protein expression and their effects on the risk of Kashin-Beck disease in the northwest Chinese Han population.Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma.No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk.Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.IL-1β, IL-8, and Matrix Metalloproteinases-1, -2, and -10 Are Enriched upon Monocyte-Breast Cancer Cell Cocultivation in a Matrigel-Based Three-Dimensional System.Matrix metalloproteinase pharmacogenomics in non-small-cell lung carcinoma.S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence.New treatment and markers of prognosis for idiopathic pulmonary fibrosis: lessons learned from translational research.Pathway-Based Kernel Boosting for the Analysis of Genome-Wide Association Studies.Featured Article: Nanoenhanced matrix metalloproteinase-responsive delivery vehicles for disease resolution and imaging
P2860
Q24618707-E140CCB2-60DC-4A47-874C-DDE70C3BB1C6Q24657797-947B3272-641C-43D3-AB93-7FD6835A9941Q27000707-0A5B94C2-A252-4454-9960-DF2F8CBAD976Q27315973-6AD8243C-9E2D-44AB-96F9-96724DF35BD7Q28390824-E0D4382A-D216-4289-B0CA-C5CA98A25F6EQ28392170-262A854A-8C89-4A5D-811F-D0CBEE595878Q28392363-E6A0F4F9-A9AF-4865-A9C0-BBA3302CAF30Q28394515-B80CD212-D979-4954-9643-853C37649847Q28394706-D5B3F0B3-4917-4953-8654-EB99DF4B6ED2Q28397184-CF4BB21A-A5C3-4862-8DFB-22D029363DF2Q29417049-B5E2519E-289D-43D5-AB6D-B940D87D279AQ30818159-1DF968DD-A59E-4D08-B8C5-7E048BC4484CQ33389830-BD6374E8-E83B-40E0-8D55-952E610F888AQ33631114-09805A0A-22EB-4875-B9A7-D5505E5B2403Q33687149-F04A1043-C45C-4049-B7F8-0E3BBCA5519EQ34031242-6712AFF7-26E1-49BF-8868-CCC838E8D6DFQ34171391-1A6BF740-BB48-4E4D-8E34-8A12F8083365Q34329984-525B0ED4-BEC9-4D3A-B647-A91E0984394DQ34429985-981D17B0-7AB8-4108-812F-0727226DB9AFQ35139929-69227650-D43A-4E83-A345-307C71070C9BQ35833218-680647CE-DAE4-4AFA-8FC2-E4F8102B994AQ36011058-BD1B9AD2-1581-42A9-A2FE-A5F1DF159D36Q36022208-FE348122-5BF7-48A8-87F2-4AC0854D3457Q36255653-5819AA76-FEC5-40B0-A225-CD7049E47CD2Q36331604-05D19B3D-7AB2-4B40-A719-5B1FC7720EC8Q36359897-249B845E-6DF5-4C2F-8BF2-54F92FB3E555Q36773349-96FDF36D-B4A5-40DA-8A6C-CEE358CE7AE8Q36821692-6CC6773F-B260-4D71-A622-A69B1B0CE241Q36824677-292FC233-02BC-4925-8911-799387ECFC5DQ36850412-FD2AA0C1-17C3-4A30-ACE3-66F871E8F480Q36955186-3C86D22F-D2D1-44E3-9D0B-5D23E02BE07EQ37111026-1D4534F6-3364-4B1E-97ED-3862276383DDQ37406444-232A2042-88EB-4E8D-9F06-8BDE6F5B074CQ37412311-9D625FDB-DA18-437E-BFC0-46A1F8DCCBE5Q37685419-65D84FFE-9939-4D97-9BA2-9816E30D4B7DQ37869122-8B11C903-E89F-4BD9-96C4-336DD17A1290Q37959812-E2992578-F36E-48FC-92BD-1CB73095FAB6Q38153815-1137D76D-30D6-47D6-94FC-173FCB74BA4EQ38635886-C8BEEFBF-6734-4B16-89E3-A9D18F164A5CQ38754729-BB7B435F-AA15-4977-9CF8-BD5D276D4D5B
P2860
Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer.
@en
Matrix metalloproteinase 1
@nl
type
label
Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer.
@en
Matrix metalloproteinase 1
@nl
prefLabel
Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer.
@en
Matrix metalloproteinase 1
@nl
P2093
P50
P1476
Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer.
@en
P2093
Albert Rosenberger
Angelika Steinwachs
Daniela Scheiner
Eckart Meese
Florian Kronenberg
Gabi Wölke
Gerhard Sybrecht
Heinz-Erich Wichmann
Hendrik Dienemann
Kirstin Mittelstrass
P304
P356
10.1158/1055-9965.EPI-07-2840
P577
2008-05-01T00:00:00Z